Impact of Anti-cytomegalovirus Treatment in the Management of Relapsing Ulcerative Colitis Requiring Vedolizumab Therapy
Clinical trial NCT04064697 · TERMINATED
Trial details
- NCT number
- NCT04064697
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2023-11-23
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.